Bioharvest Sciences (BHST) FCF Margin (2023 - 2026)
Bioharvest Sciences (BHST) posted FCF Margin of -25.16% for the quarter ended Jun 30, 2026, down 15.01 percentage points from -10.15% a year earlier and down 15.92 percentage points from the prior quarter.
Bioharvest Sciences (BHST) FCF Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Bioharvest Sciences was -17.68%, down 1.62 percentage points year-over-year; for the year ended Dec 31, 2025, it was -14.12%, up 1.17 percentage points from the prior year.
- In prior years, Bioharvest Sciences' FCF Margin was -15.28% in the year ended Dec 31, 2024 (+40.34 pp) and -55.62% in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly FCF Margin since the quarter ended Dec 31, 2024.
- On a year-over-year basis, FCF Margin increased in five of the last eight quarters, with an average year-over-year change of +2.27 percentage points.
- The strongest year-over-year quarter for FCF Margin in the past five years was the quarter ended Dec 31, 2024, with a gain of 32.38 percentage points; the weakest was the quarter ended Jun 30, 2026, with a drop of 15.01 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -9.24% (quarter ended Mar 31, 2026), -17.63% (quarter ended Dec 31, 2025) and -18.37% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Bioharvest Sciences | 26.70 Mn | -43.69 Mn | 5.08 Mn | -25.16% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.16% |
| Mar 31, 2026 | -9.24% |
| Dec 31, 2025 | -17.63% |
| Sep 30, 2025 | -18.37% |
| Jun 30, 2025 | -10.15% |
| Mar 31, 2025 | -9.45% |
| Dec 31, 2024 | -27.43% |
| Sep 30, 2024 | -19.07% |
| Jun 30, 2024 | 2.27% |
| Mar 31, 2024 | -13.90% |
| Dec 31, 2023 | -59.80% |
| Sep 30, 2023 | -17.13% |
Bioharvest Sciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BHST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BHST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BHST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();